Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tony Liu

Interventional Pain Medicine Covina, CA Doctor of Osteopathy

NPI 1609106459 CMS profile 1337829

233 W Badillo St Ste D, Covina, CA 91723

Open in the dashboard

General payments

$19,064

46 records reported · program years 2019–2025

Research payments

$16

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tony Liu of Covina, CA is reported in the CMS Open Payments database as having received $19,064 across 46 general payments and $16 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $88 1
2024 General $22 1
2023 General $121 1
2022 General $52 1
2021 General $1,071 17
2021 Research $16 1
2020 General $1,286 12
2019 General $16,424 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tony Liu
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Tony Liu were reported at $88. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Tony Liu Interventional Pain Medicine median Middle half National median
2019 $16,424 $684 $216–$2,079 $163
2020 $1,286 $382 $122–$1,109 $114
2021 $1,071 $552 $167–$1,554 $132
2022 $52 $605 $187–$1,924 $149
2023 $121 $671 $195–$1,915 $160
2024 $22 $684 $206–$1,837 $164
2025 $88 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $15,947 8 payments
  2. Nevro Corp. $1,517 15 payments
  3. SPR Therapeutics, Inc $287 4 payments
  4. Medtronic, Inc. $257 4 payments
  5. Boston Scientific Corporation $145 2 payments
  6. Amarin Pharma Inc. $144 1 payment
  7. Allergan Inc. $124 1 payment
  8. Gilead Sciences, Inc. $121 1 payment
  9. Painteq LLC $115 1 payment
  10. Avanos Medical $107 1 payment
  11. Other $300 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $15,000 1 payment
  2. Food and Beverage $2,410 36 payments
  3. Travel and Lodging $1,654 9 payments
Products named General payments · program years 2019–2025
  1. SYNCHROMED $15,000 1 payment
  2. Senza Spinal Cord Stimulation System $1,286 12 payments
  3. INTELLIS $947 7 payments
  4. SPRINT PNS System $287 4 payments
  5. Omnia $231 3 payments
  6. KYPHON Balloon Kyphoplasty $228 2 payments
  7. Vascepa $144 1 payment
  8. BOTOX $124 1 payment
  9. Vemlidy $121 1 payment
  10. WAVEWRITER ALPHA $120 1 payment
  11. Other $420 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Saluda Medical Americas, Inc. $16 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$81

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

0%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 15 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$6,986

Medicare's payments for the services billed

Medicare patients

16

Average age 67

Services billed

61

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Atrial fibrillation 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

47 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record